Research - 7investing 7investing
Stock Tips Mobile Menu Dropdown Icon

Stock Market Research

Better investing begins with better research.

7investing Stock Market Research

Being your own investor doesn’t mean you have to go it alone. Improve your investing insights with the stock market research of the 7investing lead advisors. 

Our team dives deeper, going beyond the tickers and trends to provide you with the credible, actionable information you need to make the right moves and achieve your stock market investing goals. Read on to stay up to date with the latest 7investing research articles, podcasts, videos, and updates on your favorite companies. 

article

Contest Matchup #2: Uber vs Rocket Lab: Rocket Lab

Mar 6, 2024

In our second of seven Stockpicking Challenge matchups, the mover of people squares up against the mover of satellites.

Featured Articles

Article

Contest Matchup #1: Celsius Holdings vs Novo Nordisk

Mar 4, 2024

In our first of seven Stockpicking Challenge matchups, the energy drink maker squares up against the weight-loss drug manufacturer.

Article

3 Takeaways from the 2024 WSJ Health Forum

Feb 27, 2024

The WSJ Health Forum showcased several new technologies and industry-wide discussions. Here were three of its biggest highlights.

Article

3 Emerging Technologies Investors Should Be Watching

Feb 26, 2024

The 2023 MIT EmTech conference showcased three important new technologies in climate tech, health care, and generative AI.

Recent Research

Article

Introducing 7investing’s Stockpicking Competition!

Mar 4, 2024

Enter to win a $1,000 Amazon gift card and a free year of 7investing.

Article

Is Tech Hiring Picking Back Up?

Feb 15, 2024

Encouraging data shows that (some) tech companies are looking for new engineering talent.

Article

AI is Bringing Synthetic Biology Back to Life

Feb 6, 2024

New AI tools could supercharge the emerging field of generative biology. The therapeutics segment might be a natural fit.

Article

Investing in the Cloud: Mission-Critical, Land-and-Expand, and Sustainable Growth

Jan 22, 2024

Guest contributor Anand Khatri from StocksCurrent describes how investors should approach the cloud computing industry.

Article

2024 NFL Mock Draft 1.0

Jan 21, 2024

7investing CEO Simon Erickson shares his mock draft outlook of what NFL fans should expect this April.

Article

Why Seres Therapeutics is My Best Buy in January

Jan 17, 2024

The market's first microbiome company is getting a good reception to its first commercially-approved drug.

Article

ZoomInfo: Time for a Turnaround?

Jan 11, 2024

The sales platform looks primed for a turnaround.

Article

How Do Renewable Energy Projects Get Evaluated?

Dec 28, 2023

7investing CEO Simon Erickson shares a primer on how renewable projects tend to be evaluated by larger energy companies.

Article

TaskUs is “Dirt Cheap”; My Review of its Q3 2023…

Dec 11, 2023

7investing advisor Anirban Mahanti shares his thoughts about TaskUs' most recent quarterly results.

Article

Is Seres Therapeutics Preparing To Be Acquired?

Nov 3, 2023

Seres Therapeutics announced great initial sales data but also a company restructuring. Is it preparing for an upcoming acquisition?